Recurrent plasmodium falciparum malaria infections in kenyan children diminish t-cell immunity to epstein barr virus lytic but not latent antigens

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Snider, Cynthia J ^a   Cole, Stephen R ^a   Chelimo, Kiprotich ^b   Sumba, Peter Odada ^b   MacDonald, Pia D M ^a   John, Chandy C ^c   Meshnick, Steven R ^a   Moormann, Ann M ^d,e  

^a University of North Carolina at Chapel Hill   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; VIRUS ANTIGEN;

ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSPOT ASSAY; EPSTEIN BARR VIRUS; EXPOSURE; FEMALE; HUMAN; IMMUNOPATHOGENESIS; INFANT; KENYA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NONHUMAN; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; T LYMPHOCYTE; ADOLESCENT; BURKITT LYMPHOMA; IMMUNOLOGY; MIXED INFECTION; PARASITOLOGY; RECURRENT DISEASE; VIROLOGY;

HUMAN HERPESVIRUS 4; PLASMODIUM FALCIPARUM;

ADOLESCENT; BURKITT LYMPHOMA; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; COINFECTION; ENZYME-LINKED IMMUNOSPOT ASSAY; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNITY, CELLULAR; INFANT; INTERFERON-GAMMA; KENYA; MALARIA, FALCIPARUM; PREVALENCE; RECURRENCE;

EID: 84858019545     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031753     Document Type: Article

References (36)

1. Klein G, (1982) Epstein-Barr virus, malaria and Burkitt's lymphoma. Scand J Infect Dis Suppl 36: 15-23.
2. Donati D, Espmark E, Kironde F, Mbidde EK, Kamya M, et al. (2006) Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment. J Infect Dis 193: 971-977.
3. Roberts DE, Quincey E, (1985) Epstein-Barr virus serology and malaria exposure in a small group of Liberian children with splenomegaly. J Trop Pediatr 31: 209-212.
4. Brady G, Macarthur GJ, Farrell PJ, (2008) Epstein-Barr virus and Burkitt lymphoma. Postgrad Med J 84: 372-377.
5. Facer CA, Playfair JH, (1989) Malaria, Epstein-Barr virus, and the genesis of lymphomas. Adv Cancer Res 53: 33-72.
6. Kafuko GW, Burkitt DP, (1970) Burkitt's lymphoma and malaria. Int J Cancer 6: 1-9.
7. Burkitt D, Wright D, (1966) Geographical and tribal distribution of the African lymphoma in Uganda. Br Med J 1: 569-573.
8. De-The G, (1979) The epidemiology of Burkitt's lymphoma: evidence for a causal association with Epstein-Barr virus. Epidemiol Rev 1: 32-54.
9. Rasti N, Falk KI, Donati D, Gyan BA, Goka BQ, et al. (2005) Circulating epstein-barr virus in children living in malaria-endemic areas. Scand J Immunol 61: 461-465.
10. Burkitt DP, (1969) Etiology of Burkitt's lymphoma-an alternative hypothesis to a vectored virus. J Natl Cancer Inst 42: 19-28.
11. Kafuko GW, Baingana N, Knight EM, Tibemanya J, (1969) Association of Burkitt's tumour and holoendemic malaria in West Nile District, Uganda: malaria as a possible aetiologic factor. East Afr Med J 46: 414-436.
12. Rochford R, Cannon MJ, Moormann AM, (2005) Endemic Burkitt's lymphoma: a polymicrobial disease? Nat Rev Microbiol 3: 182-187.
13. Rickinson AB, Kieff E, (2007) Epstein-Barr Virus. In: Knipe DM, Howley PM, editors. Fields Virology. Fifth ed Philadelphia, PA Lippincott Williams & Wilkins.
14. Chene A, Donati D, Guerreiro-Cacais AO, Levitsky V, Chen Q, et al. (2007) A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathog 3: e80.
15. Moss DJ, Rickinson AB, Pope JH, (1978) Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int J Cancer 22: 662-668.
16. Moormann AM, Chelimo K, Sumba PO, Tisch DJ, Rochford R, et al. (2007) Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children. J Infect Dis 195: 799-808.
17. Young LS, Rickinson AB, (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4: 757-768.
18. Munz C, (2005) Immune Response and Evasion in the Host-EBV Interaction. In: Robertson ES, editors. Epstein-Barr Virus Norfolk, England Cister Academic Press pp. 197-231.
19. Lam KM, Syed N, Whittle H, Crawford DH, (1991) Circulating Epstein-Barr virus-carrying B cells in acute malaria. Lancet 337: 876-878.
20. Whittle HC, Brown J, Marsh K, Blackman M, Jobe O, et al. (1990) The effects of Plasmodium falciparum malaria on immune control of B lymphocytes in Gambian children. Clin Exp Immunol 80: 213-218.
21. Whittle HC, Brown J, Marsh K, Greenwood BM, Seidelin P, et al. (1984) T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria. Nature 312: 449-450.
22. Gunapala DE, Facer CA, Davidson R, Weir WR, (1990) In vitro analysis of Epstein-Barr virus: host balance in patients with acute Plasmodium falciparum malaria. I. Defective T-cell control. Parasitol Res 76: 531-535.
23. Njie R, Bell AI, Jia H, Croom-Carter D, Chaganti S, et al. (2009) The effects of acute malaria on Epstein-Barr virus (EBV) load and EBV-specific T cell immunity in Gambian children. J Infect Dis 199: 31-38.
24. Morrow RH, Gutensohn N, Smith PG, (1976) Epstein-Barr virus-malaria interaction models for Burkitt's lymphoma: implications for preventive trials. Cancer Res 36: 667-669.
25. Morrow RH, Kisuule A, Pike MC, Smith PG, (1976) Burkitt's lymphoma in the Mengo Districts of Uganda: epidemiologic features and their relationship to malaria. J Natl Cancer Inst 56: 479-483.
26. Moss DJ, Burrows SR, Castelino DJ, Kane RG, Pope JH, et al. (1983) A comparison of Epstein-Barr virus-specific T-cell immunity in malaria-endemic and-nonendemic regions of Papua New Guinea. Int J Cancer 31: 727-732.
27. Moormann AM, Chelimo K, Sumba OP, Lutzke ML, Ploutz-Snyder R, et al. (2005) Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis 191: 1233-1238.
28. Piriou E, Kimmel R, Chelimo K, Middeldorp JM, Odada PS, et al. (2009) Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya. J Med Virol 81: 1088-1093.
29. Hislop AD, Annels NE, Gudgeon NH, Leese AM, Rickinson AB, (2002) Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection. J Exp Med 195: 893-905.
30. Moormann AM, John CC, Sumba PO, Tisch D, Embury P, et al. (2006) Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen-1 and thrombospondin-related adhesive protein in residents of a malaria holoendemic area. Am J Trop Med Hyg 74: 585-590.
31. Moormann AM, Sumba PO, Tisch DJ, Embury P, King CH, et al. (2009) Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen 1 and thrombospondin-related adhesive protein immunodominant epitopes in a highland population from Western Kenya. Am J Trop Med Hyg 81: 489-495.
32. Moormann AM, (2009) How might infant and paediatric immune responses influence malaria vaccine efficacy? Parasite Immunol 31: 547-559.
33. Legoff J, Amiel C, Calisonni O, Fromentin D, Rajoely B, et al. (2004) Early impairment of CD8+ T cells immune response against Epstein-Barr virus (EBV) antigens associated with high level of circulating mononuclear EBV DNA load in HIV infection. J Clin Immunol 24: 125-134.
34. Bloland PB, Boriga DA, Ruebush TK, McCormick JB, Roberts JM, et al. (1999) Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children. Am J Trop Med Hyg 60: 641-648.
35. Abu-Raddad LJ, Patnaik P, Kublin JG, (2006) Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 314: 1603-1606.
36. Singer JD, Willett JB, (2003) Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence New York Oxford University Press.